Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential-Reference-Cited by-同舟云学术

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Published:2010-09-01 Issue:9 Volume:59 Page:2087-2093
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:

Author:

Peakman Mark¹,von Herrath Matthias²

Affiliation:

1. Department of Immunobiology, National Institute for Health Research, Comprehensive Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust, King's College London, London, U.K.;

2. Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, La Jolla, California.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://journals.org/diabetes/diabetes/article-pdf/59/9/2087/508631/zdb00910002087.pdf

Reference41 articles.

1. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes;Petersen;Clin Exp Immunol,2003

2. Plasmacytoid dendritic cells mediate oral tolerance;Goubier;Immunity,2008

3. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10;Burkhart;Int Immunol,1999

4. CD4+CD25+Foxp3+ T regulatory cells are not involved in oral desensitization;Mori;Int J Immunopathol Pharmacol,2010

5. Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy;Falb;Eur J Immunol,1996

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways;Metabolism and Target Organ Damage;2024-05-16

2. Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice;Vaccines;2024-03-06

3. Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity;Advanced NanoBiomed Research;2023-01-29

4. Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials;Expert Opinion on Emerging Drugs;2023-01-02

5. DMPPred: a tool for identification of antigenic regions responsible for inducing type 1 diabetes mellitus;Briefings in Bioinformatics;2022-12-15